皮膚科用機器市場規模、シェア、動向、2031年までの世界予測

皮膚科用機器市場の規模は、2026年に約93億2,000万米ドルとなり、予測期間中に年平均成長率（CAGR）13.7%で推移し、2031年には177億3,000万米ドルに達するとMarketsandMarketsでは予測しています。皮膚がん、ニキビ、乾癬、色素沈着障害などの皮膚疾患の有病率が増加していることや、低侵襲・非侵襲的な美容施術への需要が高まっていることが、先進的な皮膚科用機器の導入を後押ししています。レーザー、高周波（RF）、HIFU（高密度焦点式超音波）、光治療、および画像診断技術の継続的な進歩により、治療の精度、安全性、臨床成績が向上しており、これも市場の成長をさらに支えています。さらに、高齢者人口の増加、ソーシャルメディアの影響による美容意識の高まり、可処分所得の増加、そして皮膚科クリニックや美容医療施設の拡大も、世界的な皮膚科用機器の普及に寄与しています。

調査範囲：

本調査レポートでは、皮膚科用機器市場を以下の区分で分析しています：タイプ別［診断用機器（画像診断装置、ダーモスコープ、顕微鏡）、治療用機器（光線療法機器、レーザー機器、電気手術装置、脂肪吸引装置、マイクロダーマブレーション機器、凍結療法機器、高周波（RF）機器、HIFU（高密度焦点式超音波）機器）］、用途別［診断用途（皮膚がん診断、炎症性皮膚疾患診断、毛髪・頭皮疾患診断、その他）、医療的治療用途（皮膚がん治療、ニキビ・乾癬治療、血管・色素性病変治療、その他）、美容治療用途（脱毛、肌の若返り・アンチエイジング、シワ除去・スキンリサーフェシング、ボディコントゥアリング・脂肪除去、タトゥー除去、その他）］、技術別（レーザー、超音波、光、凍結療法、RF、その他）、エンドユーザー別（病院、皮膚科クリニック・医療施設、美容センター、在宅ケア）、および地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ）。本レポートは、皮膚科用機器市場の成長を左右する主要な促進要因、阻害要因、機会、課題について包括的な概要を提供します。また、主要な業界プレーヤーに関する詳細な分析を行い、そのビジネスモデル、ソリューション、主要戦略、最近の買収や提携関係に焦点を当てています。さらに、市場に参入している新興スタートアップ企業の競争分析も含まれています。

本レポートを購入する理由：

本レポートは、市場全体および各セグメントの推定収益データを提供することで、皮膚科用機器業界における市場リーダーや新規参入企業を支援します。ステークホルダーが競争環境を理解し、より効果的な事業のポジショニングや適切な市場参入戦略を策定できるよう支援することを目的としています。さらに、主要な促進要因、阻害要因、機会、課題など、市場の動向に関する洞察も提供します。

本レポートでは、皮膚科用機器市場の成長に影響を与える以下の要素について分析・解説しています。

主要な促進要因（皮膚疾患や皮膚がんの有病率上昇、低侵襲・非侵襲的な美容施術への需要拡大、高齢化の進行と加齢に伴う皮膚疾患の負担増、美容意識の高まり、ソーシャルメディアの影響、外見への関心の高まり）、阻害要因（医療機器に対する厳しい規制要件、施術に伴う有害事象や合併症のリスク）、機会（新興国における皮膚科サービスの拡大、可処分所得の増加と中間層の拡大）、および課題（低価格メーカーによる価格競争、高度な皮膚科用機器の高価格化、美容施術に対する医療費償還の制限）

• 製品開発・イノベーション：皮膚科用機器市場における次世代技術、研究開発（R&D）活動、新製品投入に関する詳細情報
• 市場開拓：有望な市場に関する包括的な情報（地域別の市場分析を含む）
• 市場の多角化：新製品、未開拓地域、最近の動向、投資活動など、市場の多角化に関する詳細情報
• 競合分析：Bausch Health Companies Inc.（カナダ）、Sisram Medical Ltd（イスラエル）、Lumenis Be Ltd.（イスラエル）、InMode Ltd.（イスラエル）、BTL Group of Companies（チェコ共和国）といった主要企業の市場シェア、成長戦略、製品ラインナップに関する詳細な評価

Report Description

The dermatology devices market is valued at around USD 9.32 billion in 2026 and is expected to reach USD 17.73 billion by 2031, reflecting a CAGR of 13.7% over the forecast period. The rising prevalence of skin disorders, including skin cancer, acne, psoriasis, and pigmentation disorders, along with growing demand for minimally invasive and non-invasive aesthetic procedures, is driving adoption of advanced dermatology devices. Ongoing advancements in laser, radiofrequency, HIFU, light-based, and imaging technologies are improving treatment precision, safety, and clinical outcomes, further supporting market growth. The growing aging population, increasing beauty consciousness influenced by social media, rising disposable incomes, and the expansion of dermatology clinics and aesthetic centers are also contributing to the adoption of dermatology devices worldwide.

“The imaging devices segment is expected to witness the fastest growth rate in the dermatology devices market, by diagnostic device type, during the forecast period.”

Based on diagnostic device type, the dermatology devices market is segmented into imaging devices, dermatoscopes, and microscopes. During the forecast period, the imaging devices segment is expected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by the increasing adoption of advanced, non-invasive imaging technologies for the early detection, diagnosis, and monitoring of skin disorders. The growing use of optical coherence tomography (OCT), high-frequency ultrasound (HFUS), and other high-resolution imaging systems enables real-time visualization of skin structures, improving diagnostic accuracy while reducing the need for invasive biopsies in many cases. Furthermore, continuous technological advancements, the rising incidence of skin cancer and other dermatological conditions, increasing demand for precise image-guided diagnosis, and growing adoption of advanced diagnostic technologies in dermatology clinics and hospitals are expected to drive rapid growth in this segment during the forecast period.

“The treatment devices segment accounted for the largest share of the dermatology devices market, by type, in 2025.”

By type, the dermatology devices market is segmented into diagnostic and treatment devices. In 2025, the treatment devices segment accounted for the largest share of the dermatology devices market. This dominance is driven by rising demand for both aesthetic and therapeutic dermatology procedures, the growing prevalence of chronic and cosmetic skin conditions such as acne, psoriasis, skin cancer, and pigmentation disorders, and a growing preference for minimally invasive and non-invasive treatment options. Additionally, ongoing advances in laser, radiofrequency, HIFU, cryotherapy, and other energy-based technologies have improved treatment precision, safety, and clinical outcomes, leading to their widespread adoption. The expanding network of dermatology and cosmetic clinics, growing consumer awareness of aesthetic treatments, rising disposable incomes, and increasing acceptance of cosmetic procedures are further supporting the growth of the treatment devices segment.

“The Asia Pacific region is expected to witness the fastest growth in the dermatology devices market during the forecast period.”

By region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia Pacific is projected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by rapid economic development, rising disposable incomes, and expanding access to healthcare across emerging economies such as China, India, Indonesia, and Thailand. The region’s large and growing population, increasing prevalence of skin disorders, rising awareness of dermatological and aesthetic treatments, and growing demand for minimally invasive procedures further support market growth. Furthermore, the expanding middle-class population, increasing investments in healthcare infrastructure, rapid growth in dermatology and aesthetic clinics, continuous adoption of advanced dermatology technologies, and the growing popularity of medical tourism in countries such as South Korea and Thailand are expected to accelerate growth in the Asia Pacific dermatology devices market during the forecast period.

The breakup of the profile of primary participants in the dermatology devices market:

• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level Executives (27%), Directors (18%), and Other Designations (55%)
• By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)

The key players in the dermatology devices market include Bausch Health Companies Inc. (Canada), Sisram Medical Ltd. (Israel), AbbVie Inc. (US), InMode Ltd. (Israel), BTL Group of Companies (Czech Republic), El.En. S.p.A. (Italy), Cutera, Inc. (US), Lumenis Be Ltd. (Israel), Cynosure Lutronic (US), Candela Corporation (US), Jeisys Medical Inc. (South Korea), HEINE Optotechnik GmbH & Co. KG (Germany), Canfield Scientific, Inc. (US), Michelson Diagnostics (UK), Genesis Biosystems, Inc. (US), FotoFinder Systems GmbH (Germany), Beijing Toplaser Technology Co., Ltd. (China), Aerolase (US), GIGAAMEDICAL (China), Dimed Laser (China), Sciton (US), Fotona (US), Lynton Lasers Ltd. (UK), Astanza Laser (US), and Courage+Khazaka electronic GmbH (Germany).

Research Coverage:

This research report categorizes the dermatology devices market by Type [Diagnostic Devices (Imaging Devices, Dermatoscopes, and Microscopes), Treatment Devices (Light Therapy Devices, Lasers, Electrosurgical Equipment, Liposuction Devices, Microdermabrasion Devices, Cryotherapy Devices, Radiofrequency Devices, and HIFU (High-Intensity Focused Ultrasound) Devices)], by Application [Diagnostic Applications (Skin Cancer Diagnosis, Inflammatory Skin Disease Diagnosis, Hair & Scalp Disorder Diagnosis, and Other Diagnostic Applications), Medical Therapeutic Applications (Skin Cancer Treatment, Acne & Psoriasis Treatment, Vascular & Pigmented Lesion Treatment, and Other Medical Therapeutic Applications), and Aesthetic Therapeutic Applications (Hair Removal, Skin Rejuvenation & Anti-aging, Wrinkle Removal & Skin Resurfacing, Body Contouring & Fat Removal, Tattoo Removal, and Other Aesthetic Therapeutic Applications)], by Technology (Laser-Based, Ultrasound-Based, Light-Based, Cryotherapy-Based, RF-Based, and Other Technologies), by End User (Hospitals, Dermatology Clinics & Medical Facilities, Beauty Centers, and Home Care Settings), and by Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides a comprehensive overview of the key drivers, restraints, opportunities, and challenges shaping growth in the dermatology devices market. It offers an in-depth analysis of the major industry players, highlighting their business models, solutions, key strategies, recent acquisitions, and agreements. Additionally, the report includes a competitive analysis of emerging startups in the dermatology devices market.

Reasons to Buy this Report:

The report will assist market leaders and new entrants in the dermatology devices industry by providing estimated revenue figures for the overall market and its subsegments. It aims to help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

Analysis of key drivers (rising prevalence of skin disorders and skin cancer, increasing demand for minimally invasive and noninvasive aesthetic procedures, growing aging population and rising burden of age-related skin conditions, and growing beauty consciousness, social media influence, and emphasis on personal appearance), restraints (stringent regulatory requirements for medical devices, risk of procedure-related adverse events and complications), opportunities (expansion of dermatology services in emerging markets, increasing disposable income and expanding middle-class population), and challenges (competitive pricing by low-cost manufacturers, high cost of advanced dermatology devices and limited reimbursement for aesthetic procedures) influencing the growth of the dermatology devices market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the dermatology devices market
• Market Development: Comprehensive information about lucrative markets; the report analyzes the dermatology devices market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the dermatology devices market
• Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Bausch Health Companies Inc. (Canada), Sisram Medical Ltd (Israel), Lumenis Be Ltd. (Israel), InMode Ltd. (Israel), and BTL Group of Companies (Czech Republic)

Table of Contents

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 37
1.3 STUDY SCOPE 37
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 37
1.3.2 INCLUSIONS AND EXCLUSIONS 38
1.3.3 YEARS CONSIDERED 39
1.4 CURRENCY CONSIDERED 39
1.5 STAKEHOLDERS 39
1.6 SUMMARY OF CHANGES 40
2 EXECUTIVE SUMMARY 41
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 41
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 42
2.3 DISRUPTIVE TRENDS SHAPING MARKET 43
2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 44
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 45
3 PREMIUM INSIGHTS 46
3.1 DERMATOLOGY DEVICES MARKET OVERVIEW 46
3.2 DERMATOLOGY DEVICES MARKET, BY TYPE, 2026 VS. 2031 47
3.3 DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2026 VS. 2031 47
3.4 DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY, 2026 VS. 2031 48
3.5 DERMATOLOGY DEVICES MARKET, BY END USER, 2026 VS. 2031 48
3.6 DERMATOLOGY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
4 MARKET OVERVIEW 50
4.1 INTRODUCTION 50
4.2 MARKET DYNAMICS 50
4.2.1 DRIVERS 51
4.2.1.1 Rising prevalence of skin disorders and skin cancer 51
4.2.1.2 Increasing demand for minimally invasive and non-invasive aesthetic procedures 51
4.2.1.3 Growing aging population and rising burden of age-related skin conditions 52
4.2.1.4 Growing beauty consciousness, social media influence, and emphasis on personal appearance 53
4.2.2 RESTRAINTS 53
4.2.2.1 Stringent regulatory requirements for medical devices 53
4.2.2.2 Risk of procedure-related adverse events and complications 54
4.2.3 OPPORTUNITIES 54
4.2.3.1 Expansion of dermatology services in emerging markets 54
4.2.3.2 Increasing disposable income and expanding middle-class population 54
4.2.4 CHALLENGES 55
4.2.4.1 Competitive pricing by low-cost manufacturers 55
4.2.4.2 High cost of advanced dermatology devices and limited reimbursement for aesthetic procedures 55
4.3 UNMET NEEDS AND WHITE SPACES 56
4.3.1 UNMET NEEDS IN DERMATOLOGY DEVICES MARKET 56
4.3.2 WHITE SPACE OPPORTUNITIES 57
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 58
4.4.1 INTERCONNECTED MARKETS 58
4.4.2 CROSS-SECTOR OPPORTUNITIES 59
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 60
4.5.1 KEY MOVES AND STRATEGIC FOCUS 60
5 INDUSTRY TRENDS 61
5.1 PORTER’S FIVE FORCES ANALYSIS 61
5.1.1 BARGAINING POWER OF SUPPLIERS 62
5.1.2 BARGAINING POWER OF BUYERS 62
5.1.3 THREAT OF NEW ENTRANTS 62
5.1.4 THREAT OF SUBSTITUTES 62
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.2 MACROECONOMIC INDICATORS 63
5.2.1 INTRODUCTION 63
5.2.2 GDP TRENDS AND FORECAST 63
5.3 SUPPLY CHAIN ANALYSIS 66
5.4 VALUE CHAIN ANALYSIS 67
5.5 ECOSYSTEM ANALYSIS 69
5.5.1 DERMATOLOGY DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 70
5.6 PRICING ANALYSIS 70
5.6.1 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY KEY PLAYER, 2024–2026 70
5.6.2 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY REGION, 2024–2026 71
5.7 TRADE ANALYSIS 72
5.7.1 IMPORT SCENARIO (HS CODE 901320) 72
5.7.2 EXPORT SCENARIO (HS CODE 901320) 73
5.8 KEY CONFERENCES & EVENTS, 2026–2027 73
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74
5.10 INVESTMENT & FUNDING SCENARIO 75
5.11 IMPACT OF 2025 US TARIFF ON DERMATOLOGY DEVICES MARKET 75
5.11.1 INTRODUCTION 75
5.11.2 KEY TARIFF RATES 76
5.11.3 PRICE IMPACT ANALYSIS 76
5.11.4 IMPACT ON REGION 77
5.11.4.1 North America 77
5.11.4.2 Europe 77
5.11.4.3 Asia Pacific 78
5.11.5 IMPACT ON END-USE INDUSTRIES 78
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 79
6.1 KEY EMERGING TECHNOLOGIES 79
6.1.1 LASER TECHNOLOGIES 79
6.1.2 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) 79
6.2 COMPLEMENTARY TECHNOLOGIES 80
6.2.1 TELEDERMATOLOGY PLATFORMS 80
6.2.2 ADVANCED CRYOGEN COOLING & SKIN COOLING TECHNOLOGIES 80
6.3 ADJACENT TECHNOLOGIES 81
6.3.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) 81
6.3.2 3D SKIN IMAGING & COMPUTER VISION 81
6.4 TECHNOLOGY/PRODUCT ROADMAP 82
6.5 PATENT ANALYSIS 83
6.5.1 LIST OF MAJOR PATENTS 84
6.5.2 LIST OF KEY PATENTS 84
6.6 FUTURE APPLICATIONS 85
6.7 IMPACT OF AI/GENERATIVE AI ON DERMATOLOGY DEVICES MARKET 86
6.7.1 INTRODUCTION 86
6.7.2 TOP USE CASES AND MARKET POTENTIAL 87
6.7.3 KEY COMPANIES IMPLEMENTING AI 88
6.7.4 FUTURE OF AI 88
7 REGULATORY LANDSCAPE AND SUSTAINABILITY 89
7.1 REGIONAL REGULATIONS AND COMPLIANCE 89
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
7.2 SUSTAINABILITY INITIATIVES 91
7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN DERMATOLOGY DEVICES 91
7.2.1.1 Eco-friendly Initiatives 92
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 92

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94
8.1 DECISION-MAKING PROCESS 94
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 94
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
8.2.2 BUYING CRITERIA 95
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 96
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 97
8.5 MARKET PROFITABILITY 98
8.5.1 REVENUE POTENTIAL 98
8.5.2 COST DYNAMICS 99
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 99
9 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE 101
9.1 INTRODUCTION 102
9.2 DIAGNOSTIC DEVICES 102
9.2.1 IMAGING DEVICES 104
9.2.1.1 MRI, Ultrasound, CT, and OCT widely used in dermatology
disease diagnosis 104
9.2.2 DERMATOSCOPES 106
9.2.2.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE
SEGMENT GROWTH 106
9.2.3 MICROSCOPES 109
9.2.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES — KEY FACTOR DRIVING SEGMENT GROWTH 109
9.3 TREATMENT DEVICES 111
9.3.1 LIGHT THERAPY DEVICES 113
9.3.1.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES TO DRIVE SEGMENT GROWTH 113
9.3.2 LASERS 115
9.3.2.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS 115
9.3.3 ELECTROSURGICAL EQUIPMENT 117
9.3.3.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH 117
9.3.4 LIPOSUCTION DEVICES 119
9.3.4.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH 119
9.3.5 MICRODERMABRASION DEVICES 121
9.3.5.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH 121
9.3.6 CRYOTHERAPY DEVICES 123
9.3.6.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ADOPTION 123
9.3.7 RADIOFREQUENCY DEVICES 125
9.3.7.1 Rising demand for minimally invasive skin rejuvenation driving RF devices segment 125
9.3.8 HIFU DEVICES 127
9.3.8.1 Growing demand for non-invasive skin lifting driving HIFU devices growth 127
9.3.9 OTHER DERMATOLOGY TREATMENT DEVICES 129
10 DERMATOLOGY DEVICES MARKET, BY APPLICATION 132
10.1 INTRODUCTION 133
10.2 DIAGNOSTIC APPLICATION 133
10.2.1 SKIN CANCER DIAGNOSIS 136
10.2.1.1 Growing emphasis on early melanoma detection to drive skin cancer diagnosis segment 136
10.2.2 INFLAMMATORY SKIN DISEASE DIAGNOSIS 138
10.2.2.1 Increasing prevalence of chronic inflammatory skin disorders to support market growth 138
10.2.3 HAIR & SCALP DISORDER DIAGNOSIS 140
10.2.3.1 Rising awareness of hair health and increasing cases of hair loss to drive demand 140
10.2.4 OTHER DIAGNOSTIC APPLICATIONS 142
10.3 MEDICAL THERAPEUTIC APPLICATIONS 144
10.3.1 SKIN CANCER TREATMENT 146
10.3.1.1 Increasing adoption of minimally invasive therapies to drive demand 146
10.3.2 ACNE & PSORIASIS TREATMENT 148
10.3.2.1 Growing preference for long-term, minimally invasive disease management to support market growth 148
10.3.3 VASCULAR & PIGMENTED LESION TREATMENT 150
10.3.3.1 Rising demand for precise cosmetic correction to accelerate device adoption 150
10.3.4 OTHER MEDICAL THERAPEUTIC APPLICATIONS 152
10.4 AESTHETIC THERAPEUTIC APPLICATIONS 154
10.4.1 HAIR REMOVAL 156
10.4.1.1 Long-lasting results continue to shift consumers toward laser-based hair removal 156
10.4.2 SKIN REJUVENATION & ANTI-AGING 158
10.4.2.1 Growing appearance consciousness and preventive aesthetic care to reshape treatment demand 158
10.4.3 WRINKLE REMOVAL & SKIN RESURFACING 160
10.4.3.1 Preference for visible results without surgery to accelerate procedure adoption 160
10.4.4 BODY CONTOURING & FAT REMOVAL 162
10.4.4.1 Growing body confidence trends to increase demand for non-surgical body sculpting 162
10.4.5 TATTOO REMOVAL 164
10.4.5.1 Changing lifestyle preferences and advances in laser technology to drive procedure demand 164
10.4.6 OTHER AESTHETIC THERAPEUTIC APPLICATIONS 166
11 DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY 169
11.1 INTRODUCTION 170
11.2 LASER-BASED 170
11.2.1 HIGH PRECISION AND BROAD CLINICAL APPLICATIONS TO DRIVE LASER-BASED SEGMENT 170
11.3 ULTRASOUND-BASED 172
11.3.1 INCREASING ADOPTION OF NON-INVASIVE SKIN LIFTING PROCEDURES TO DRIVE ULTRASOUND-BASED SEGMENT 172
11.4 LIGHT-BASED 174
11.4.1 EXPANDING USE OF NON-LASER LIGHT THERAPIES TO SUPPORT LIGHT-BASED SEGMENT 174
11.5 CRYOTHERAPY-BASED 176
11.5.1 INCREASING PREFERENCE FOR RAPID, OFFICE-BASED LESION TREATMENT TO SUPPORT SEGMENT 176
11.6 RF-BASED 178
11.6.1 ADVANCEMENTS IN COLLAGEN REMODELING TECHNOLOGIES TO DRIVE RF-BASED SEGMENT 178
11.7 OTHER TECHNOLOGIES 180
12 DERMATOLOGY DEVICES MARKET, BY END USER 183
12.1 INTRODUCTION 184
12.2 HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES 184
12.2.1 INCREASING PATIENT PREFERENCE FOR SPECIALIZED DERMATOLOGY CARE TO DRIVE GROWTH OF SEGMENT 184
12.3 BEAUTY CENTERS 186
12.3.1 GROWING CONSUMER DEMAND FOR NON-INVASIVE AESTHETIC PROCEDURES TO DRIVE BEAUTY CENTERS SEGMENT 186
12.4 HOME CARE SETTINGS 188
12.4.1 GROWING AVAILABILITY OF PORTABLE AND EASY-TO-USE DEVICES TO SUPPORT THIS SEGMENT 188
13 DERMATOLOGY DEVICES MARKET, BY REGION 191
13.1 INTRODUCTION 192
13.2 NORTH AMERICA 192
13.2.1 US 198
13.2.1.1 High healthcare expenditure and technological innovation to drive market growth 198
13.2.2 CANADA 203
13.2.2.1 Growing aging population and preference for minimally invasive procedures driving market growth 203
13.3 EUROPE 207
13.3.1 GERMANY 212
13.3.1.1 Increasing demand for minimally invasive dermatology procedures to drive market growth 212
13.3.2 UK 217
13.3.2.1 Increasing skin cancer incidence to drive market growth 217
13.3.3 FRANCE 221
13.3.3.1 Growing social acceptance of medical aesthetic treatments to drive market growth 221
13.3.4 ITALY 226
13.3.4.1 Growing medical tourism for aesthetic procedures to drive market growth 226
13.3.5 SPAIN 230
13.3.5.1 Increasing preference for minimally invasive aesthetic treatments to drive market growth 230
13.3.6 REST OF EUROPE 235
13.4 ASIA PACIFIC 239
13.4.1 CHINA 245
13.4.1.1 Increasing availability of digital aesthetic consultation platforms to drive market growth 245
13.4.2 JAPAN 249
13.4.2.1 Growing demand for non-surgical aesthetic procedures to drive market growth 249
13.4.3 INDIA 253
13.4.3.1 Rising awareness and affordability of aesthetic treatments to drive market growth 253
13.4.4 REST OF ASIA PACIFIC 258
13.5 LATIN AMERICA 262
13.5.1 BRAZIL 267
13.5.1.1 Expanding medical tourism to drive market growth 267
13.5.2 MEXICO 272
13.5.2.1 Expanding medical aesthetics industry to drive market growth 272
13.5.3 REST OF LATIN AMERICA 276
13.6 MIDDLE EAST & AFRICA 281
14 COMPETITIVE LANDSCAPE 286
14.1 INTRODUCTION 286
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 286
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DERMATOLOGY DEVICES MARKET 286
14.3 REVENUE ANALYSIS, 2023–2025 288
14.4 MARKET SHARE ANALYSIS, 2025 289
14.4.1 MARKET SHARE ANALYSIS, 2025 289
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 291
14.5.1 STARS 291
14.5.2 EMERGING LEADERS 291
14.5.3 PERVASIVE PLAYERS 291
14.5.4 PARTICIPANTS 291
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 293
14.5.5.1 Company footprint 293
14.5.5.2 Region footprint 293
14.5.5.3 Type footprint 294
14.5.5.4 Application footprint 294
14.5.5.5 End user footprint 295
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 295
14.6.1 PROGRESSIVE COMPANIES 295
14.6.2 RESPONSIVE COMPANIES 295
14.6.3 DYNAMIC COMPANIES 296
14.6.4 STARTING BLOCKS 296
14.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 297
14.6.5.1 Detailed list of key startups/SMEs 297
14.6.5.2 Competitive benchmarking of startups/SMEs (1/2) 298
14.6.5.3 Competitive benchmarking of startups/SMEs (2/2) 298
14.7 COMPANY VALUATION & FINANCIAL METRICS 299
14.7.1 FINANCIAL METRICS 299
14.7.2 COMPANY VALUATION 299
14.8 BRAND/PRODUCT COMPARISON 300
14.9 COMPETITIVE SCENARIO 301
14.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 301
14.9.2 DEALS 303
14.9.2.1 Expansions 304
15 COMPANY PROFILES 305
15.1 KEY PLAYERS 305
15.1.1 BAUSCH HEALTH COMPANIES INC. 305
15.1.1.1 Business overview 305
15.1.1.2 Products offered 306
15.1.1.3 Recent developments 307
15.1.1.3.1 Product launches & approvals 307
15.1.1.3.2 Deals 307
15.1.1.4 MnM view 308
15.1.1.4.1 Right to win 308
15.1.1.4.2 Strategic choices 308
15.1.1.4.3 Weaknesses & competitive threats 308
15.1.2 SISRAM MEDICAL LTD 309
15.1.2.1 Business overview 309
15.1.2.2 Products offered 311
15.1.2.3 Recent developments 311
15.1.2.3.1 Product launches & approvals 311
15.1.2.4 MnM view 312
15.1.2.4.1 Right to win 312
15.1.2.4.2 Strategic choices 312
15.1.2.4.3 Weaknesses & competitive threats 312
15.1.3 LUMENIS BE LTD. 313
15.1.3.1 Business overview 313
15.1.3.2 Products offered 313
15.1.3.3 Recent developments 314
15.1.3.3.1 Product launches & approvals 314
15.1.3.3.2 Deals 314
15.1.3.4 MnM view 315
15.1.3.4.1 Right to win 315
15.1.3.4.2 Strategic choices 315
15.1.3.4.3 Weaknesses & competitive threats 315
15.1.4 INMODE LTD 316
15.1.4.1 Business overview 316
15.1.4.2 Products offered 317
15.1.4.3 Recent developments 318
15.1.4.3.1 Product launches & approvals 318
15.1.4.4 MnM view 319
15.1.4.4.1 Right to win 319
15.1.4.4.2 Strategic choices 319
15.1.4.4.3 Weaknesses & competitive threats 319
15.1.5 BTL GROUP OF COMPANIES 320
15.1.5.1 Business overview 320
15.1.5.2 Products offered 320
15.1.5.3 MnM view 321
15.1.5.3.1 Right to win 321
15.1.5.3.2 Strategic choices 321
15.1.5.3.3 Weaknesses & competitive threats 321
15.1.6 EL.EN. S.P.A. 322
15.1.6.1 Business overview 322
15.1.6.2 Products offered 324
15.1.6.3 Recent developments 324
15.1.6.3.1 Product launches & approvals 324
15.1.7 ABBVIE INC. 325
15.1.7.1 Business overview 325
15.1.7.2 Products offered 326
15.1.7.3 Recent developments 327
15.1.7.3.1 Product launches & approvals 327
15.1.8 CYNOSURE LUTRONIC 328
15.1.8.1 Business overview 328
15.1.8.2 Products offered 329
15.1.8.3 Recent developments 329
15.1.8.3.1 Product launches & approvals 329
15.1.8.3.2 Deals 330
15.1.9 CUTERA, INC. 331
15.1.9.1 Business overview 331
15.1.9.2 Products offered 332
15.1.9.3 Recent developments 332
15.1.9.3.1 Product launches & approvals 332
15.1.10 FOTONA 333
15.1.10.1 Business overview 333
15.1.10.2 Products offered 333
15.1.10.3 Recent developments 334
15.1.10.3.1 Expansions 334
15.2 OTHER PLAYERS 335
15.2.1 CANDELA CORPORATION 335
15.2.2 JEISYS MEDICAL INC. 336
15.2.3 AEROLASE 337
15.2.4 SCITON 338
15.2.5 ASTANZA LASER 339
15.2.6 HEINE OPTOTECHNIK GMBH & CO. KG 340
15.2.7 CANFIELD SCIENTIFIC, INC. 341
15.2.8 MICHELSON DIAGNOSTICS 342
15.2.9 GENESIS BIOSYSTEMS, INC 343
15.2.10 FOTOFINDER SYSTEMS GMBH 344
15.2.11 BEIJING TOPLASER TECHNOLOGY CO., LTD. 345
15.2.12 GIGAAMEDICAL 346
15.2.13 DIMED LASER 347
15.2.14 LYNTON LASERS LTD 347
15.2.15 COURAGE+KHAZAKA ELECTRONIC GMBH 349
16 RESEARCH METHODOLOGY 350
16.1 RESEARCH DATA 350
16.2 SECONDARY DATA 351
16.2.1 LIST OF SECONDARY SOURCES 351
16.2.1.1 Key data from secondary sources 352
16.2.2 PRIMARY DATA 352
16.2.2.1 List of primary sources 353
16.2.2.2 Key data from primary sources 353
16.2.2.3 Key industry insights 355
16.2.2.4 Breakdown of primary interviews 355
16.3 MARKET SIZE ESTIMATION 356
16.3.1 TOTAL MARKET SIZE: DERMATOLOGY DEVICE MARKET 356
16.3.2 BOTTOM-UP APPROACH 356
16.3.2.1 Approach 1: Revenue estimation of key players 356
16.3.2.2 Approach 2: Study of annual reports and investor presentations 357
16.3.2.3 Approach 3: Primary interviews 357
16.3.2.4 Growth forecast 357
16.3.2.5 CAGR projections 358
16.3.3 TOP-DOWN APPROACH 358
16.4 DATA TRIANGULATION 359
16.5 RESEARCH ASSUMPTIONS 360
16.5.1 STUDY-RELATED ASSUMPTIONS 360
16.6 STUDY ASSUMPTIONS 360
16.6.1 PARAMETRIC ASSUMPTIONS 361
16.6.2 GROWTH RATE ASSUMPTIONS 361
16.7 RESEARCH LIMITATIONS 362
16.8 RISK ASSESSMENT 362
17 APPENDIX 363
17.1 DISCUSSION GUIDE 363
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 367
17.3 CUSTOMIZATION OPTIONS 368
17.4 RELATED REPORTS 369
17.5 AUTHOR DETAILS 370

LIST OF TABLES

TABLE 1 DERMATOLOGY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 62
TABLE 2 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2023–2030 63
TABLE 3 NORTH AMERICA: MACROECONOMIC INDICATORS 65
TABLE 4 EUROPE: MACROECONOMIC INDICATORS 65
TABLE 5 ASIA PACIFIC: MACROECONOMIC INDICATORS 65
TABLE 6 LATIN AMERICA: MACROECONOMIC INDICATORS 65
TABLE 7 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 66
TABLE 8 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY KEY PLAYER,
2024–2026 (USD) 71
TABLE 9 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY REGION,
2024–2026 (USD) 71
TABLE 10 IMPORT DATA FOR HS CODE 901320-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 72
TABLE 11 EXPORT DATA FOR HS CODE 901320-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 73
TABLE 12 DERMATOLOGY DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 73
TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES 76
TABLE 14 KEY PATENTS IN DERMATOLOGY DEVICES MARKET, 2023–2026 84
TABLE 15 KEY COMPANIES IMPLEMENTING AI IN DERMATOLOGY DEVICES MARKET 88
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%) 95
TABLE 22 KEY BUYING CRITERIA, BY TYPE 95
TABLE 23 ADOPTION BARRIERS & INTERNAL CHALLENGES 96
TABLE 24 DERMATOLOGY DEVICES MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 97
TABLE 25 DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 102
TABLE 26 DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 102
TABLE 27 DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY REGION,
2024–2031 (USD MILLION) 103
TABLE 28 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 103
TABLE 29 EUROPE: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 103
TABLE 30 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 104
TABLE 31 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 104
TABLE 32 DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES, BY REGION,
2024–2031 (USD MILLION) 105
TABLE 33 NORTH AMERICA: DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 105
TABLE 34 EUROPE: DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 105
TABLE 35 ASIA PACIFIC: DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 106
TABLE 36 LATIN AMERICA: DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 106
TABLE 37 DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES, BY REGION,
2024–2031 (USD MILLION) 107
TABLE 38 NORTH AMERICA: DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES,
BY COUNTRY, 2024–2031 (USD MILLION) 107
TABLE 39 EUROPE: DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 108
TABLE 40 ASIA PACIFIC: DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES,
BY COUNTRY, 2024–2031 (USD MILLION) 108
TABLE 41 LATIN AMERICA: DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES,
BY COUNTRY, 2024–2031 (USD MILLION) 108
TABLE 42 DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY REGION,
2024–2031 (USD MILLION) 109
TABLE 43 NORTH AMERICA: DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES,
BY COUNTRY, 2024–2031 (USD MILLION) 109
TABLE 44 EUROPE: DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY COUNTRY,
2024–2031 (USD MILLION) 110
TABLE 45 ASIA PACIFIC: DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 46 LATIN AMERICA: DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 47 TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 111
TABLE 48 DERMATOLOGY DEVICES MARKET FOR TREATMENT DEVICES, BY REGION,
2024–2031 (USD MILLION) 111
TABLE 49 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR TREATMENT DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 112
TABLE 50 EUROPE: DERMATOLOGY DEVICES MARKET FOR TREATMENT DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 112
TABLE 51 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR TREATMENT DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 112
TABLE 52 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR TREATMENT DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 53 TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY REGION,
2024–2031 (USD MILLION) 113
TABLE 54 NORTH AMERICA: TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 55 EUROPE: TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 56 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 57 LATIN AMERICA: TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 115
TABLE 58 TREATMENT DEVICES MARKET FOR LASER, BY REGION,
2024–2031 (USD MILLION) 115
TABLE 59 NORTH AMERICA: TREATMENT DEVICES MARKET FOR LASER, BY COUNTRY,
2024–2031 (USD MILLION) 116
TABLE 60 EUROPE: TREATMENT DEVICES MARKET FOR LASER, BY COUNTRY,
2024–2031 (USD MILLION) 116
TABLE 61 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR LASER, BY COUNTRY,
2024–2031 (USD MILLION) 116
TABLE 62 LATIN AMERICA: TREATMENT DEVICES MARKET FOR LASER, BY COUNTRY,
2024–2031 (USD MILLION) 117
TABLE 63 TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY REGION, 2024–2031 (USD MILLION) 118
TABLE 64 NORTH AMERICA: TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 65 EUROPE: TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT,
BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 66 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 67 LATIN AMERICA: TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 68 TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY REGION,
2024–2031 (USD MILLION) 120
TABLE 69 NORTH AMERICA: TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 70 EUROPE: TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 71 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 72 LATIN AMERICA: TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 73 TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY REGION, 2024–2031 (USD MILLION) 122
TABLE 74 NORTH AMERICA: TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 75 EUROPE: TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 76 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 77 LATIN AMERICA: TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 78 TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES, BY REGION,
2024–2031 (USD MILLION) 124
TABLE 79 NORTH AMERICA: TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 80 EUROPE: TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 81 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 82 LATIN AMERICA: TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 83 TREATMENT DEVICES MARKET FOR RADIOFREQUENCY DEVICES, BY REGION, 2024–2031 (USD MILLION) 126
TABLE 84 NORTH AMERICA: TREATMENT DEVICES MARKET FOR RADIOFREQUENCY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 85 EUROPE: TREATMENT DEVICES MARKET FOR RADIOFREQUENCY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 86 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR RADIOFREQUENCY DEVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 87 LATIN AMERICA: TREATMENT DEVICES MARKET FOR RADIOFREQUENCY DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 88 TREATMENT DEVICES MARKET FOR HIFU DEVICES, BY REGION,
2024–2031 (USD MILLION) 128
TABLE 89 NORTH AMERICA: TREATMENT DEVICES MARKET FOR HIFU DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 90 EUROPE: TREATMENT DEVICES MARKET FOR HIFU DEVICES, BY COUNTRY,
2024–2031 (USD MILLION) 128
TABLE 91 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR HIFU DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 92 LATIN AMERICA: TREATMENT DEVICES MARKET FOR HIFU DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 93 TREATMENT DEVICES MARKET FOR OTHER DERMATOLOGY TREATMENT DEVICES, BY REGION, 2024–2031 (USD MILLION) 130
TABLE 94 NORTH AMERICA: TREATMENT DEVICES MARKET FOR OTHER DERMATOLOGY TREATMENT DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 95 EUROPE: TREATMENT DEVICES MARKET FOR OTHER DERMATOLOGY TREATMENT DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 96 ASIA PACIFIC: TREATMENT DEVICES MARKET FOR OTHER DERMATOLOGY TREATMENT DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 97 LATIN AMERICA: TREATMENT DEVICES MARKET FOR OTHER DERMATOLOGY TREATMENT DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 98 DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 133
TABLE 99 DERMATOLOGY DEVICES MARKET, BY DIAGNOSTIC APPLICATION,
2024–2031 (USD MILLION) 134
TABLE 100 DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC APPLICATION, BY REGION, 2024–2031 (USD MILLION) 134
TABLE 101 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 102 EUROPE: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 103 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 104 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 105 DIAGNOSTIC APPLICATION MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2024–2031 (USD MILLION) 136
TABLE 106 NORTH AMERICA: DIAGNOSTIC APPLICATION MARKET FOR SKIN CANCER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 107 EUROPE: DIAGNOSTIC APPLICATION MARKET FOR SKIN CANCER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 108 ASIA PACIFIC: DIAGNOSTIC APPLICATION MARKET FOR SKIN CANCER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 109 LATIN AMERICA: DIAGNOSTIC APPLICATION MARKET FOR SKIN CANCER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 110 DIAGNOSTIC APPLICATION MARKET FOR INFLAMMATORY SKIN DISEASE DIAGNOSIS, BY REGION, 2024–2031 (USD MILLION) 138
TABLE 111 NORTH AMERICA: DIAGNOSTIC APPLICATION MARKET FOR INFLAMMATORY SKIN DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 112 EUROPE: DIAGNOSTIC APPLICATION MARKET FOR INFLAMMATORY SKIN DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 113 ASIA PACIFIC: DIAGNOSTIC APPLICATION MARKET FOR INFLAMMATORY SKIN DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 114 LATIN AMERICA: DIAGNOSTIC APPLICATION MARKET FOR INFLAMMATORY SKIN DISEASE DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 115 DIAGNOSTIC APPLICATION MARKET FOR HAIR & SCALP DISORDER DIAGNOSIS,
BY REGION, 2024–2031 (USD MILLION) 140
TABLE 116 NORTH AMERICA: DIAGNOSTIC APPLICATION MARKET FOR HAIR & SCALP DISORDER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 140
TABLE 117 EUROPE: DIAGNOSTIC APPLICATION MARKET FOR HAIR & SCALP DISORDER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 118 ASIA PACIFIC: DIAGNOSTIC APPLICATION MARKET FOR HAIR & SCALP DISORDER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 119 LATIN AMERICA: DIAGNOSTIC APPLICATION MARKET FOR HAIR & SCALP DISORDER DIAGNOSIS, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 120 DIAGNOSTIC APPLICATION MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,
BY REGION, 2024–2031 (USD MILLION) 142
TABLE 121 NORTH AMERICA: DIAGNOSTIC APPLICATION MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 122 EUROPE: DIAGNOSTIC APPLICATION MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 123 ASIA PACIFIC: DIAGNOSTIC APPLICATION MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 124 LATIN AMERICA: DIAGNOSTIC APPLICATION MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 125 DERMATOLOGY DEVICES MARKET, BY MEDICAL THERAPEUTIC APPLICATION, 2024–2031 (USD MILLION) 144
TABLE 126 DERMATOLOGY DEVICES MARKET FOR MEDICAL THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 144
TABLE 127 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 128 EUROPE: DERMATOLOGY DEVICES MARKET FOR MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 129 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 130 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 131 MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR SKIN CANCER TREATMENT, BY REGION, 2024–2031 (USD MILLION) 146
TABLE 132 NORTH AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR SKIN CANCER TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 133 EUROPE: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR SKIN CANCER TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 134 ASIA PACIFIC: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR SKIN CANCER TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 135 LATIN AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR SKIN CANCER TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 136 MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR ACNE & PSORIASIS TREATMENT, BY REGION, 2024–2031 (USD MILLION) 148
TABLE 137 NORTH AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR ACNE & PSORIASIS TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 138 EUROPE: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR ACNE & PSORIASIS TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 139 ASIA PACIFIC: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR ACNE & PSORIASIS TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 140 LATIN AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR ACNE & PSORIASIS TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 141 MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR VASCULAR & PIGMENTED LESION TREATMENT, BY REGION, 2024–2031 (USD MILLION) 150
TABLE 142 NORTH AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR VASCULAR & PIGMENTED LESION TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 143 EUROPE: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR VASCULAR & PIGMENTED LESION TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 144 ASIA PACIFIC: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR VASCULAR & PIGMENTED LESION TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 145 LATIN AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR VASCULAR & PIGMENTED LESION TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 146 MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR OTHER MEDICAL THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 152
TABLE 147 NORTH AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR OTHER MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 148 EUROPE: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR OTHER MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 149 ASIA PACIFIC: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR OTHER MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 150 LATIN AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET FOR OTHER MEDICAL THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 151 DERMATOLOGY DEVICES MARKET, BY AESTHETIC THERAPEUTIC APPLICATION, 2024–2031 (USD MILLION) 154
TABLE 152 DERMATOLOGY DEVICES MARKET FOR AESTHETIC THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 155
TABLE 153 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 154 EUROPE: DERMATOLOGY DEVICES MARKET FOR AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 155 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 156 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 157 AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR HAIR REMOVAL, BY REGION, 2024–2031 (USD MILLION) 157
TABLE 158 NORTH AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR HAIR REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 159 EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR HAIR REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 160 ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR HAIR REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 161 LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR HAIR REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 162 AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR SKIN REJUVENATION & ANTI-AGING, BY REGION, 2024–2031 (USD MILLION) 159
TABLE 163 NORTH AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR SKIN REJUVENATION & ANTI-AGING, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 164 EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR SKIN REJUVENATION & ANTI-AGING, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 165 ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR SKIN REJUVENATION & ANTI-AGING, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 166 LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR SKIN REJUVENATION & ANTI-AGING, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 167 AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR WRINKLE REMOVAL & SKIN RESURFACING, BY REGION, 2024–2031 (USD MILLION) 161
TABLE 168 NORTH AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR WRINKLE REMOVAL & SKIN RESURFACING, BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 169 EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR WRINKLE REMOVAL & SKIN RESURFACING, BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 170 ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR WRINKLE REMOVAL & SKIN RESURFACING, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 171 LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR WRINKLE REMOVAL & SKIN RESURFACING, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 172 AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR BODY CONTOURING & FAT REMOVAL, BY REGION, 2024–2031 (USD MILLION) 163
TABLE 173 NORTH AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR BODY CONTOURING & FAT REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 174 EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR BODY CONTOURING & FAT REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 175 ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR BODY CONTOURING & FAT REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 176 LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR BODY CONTOURING & FAT REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 177 AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR TATTOO REMOVAL, BY REGION, 2024–2031 (USD MILLION) 165
TABLE 178 NORTH AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR TATTOO REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 179 EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR TATTOO REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 180 ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR TATTOO REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 181 LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR TATTOO REMOVAL, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 182 AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR OTHER AESTHETIC THERAPEUTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 167
TABLE 183 NORTH AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR OTHER AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY,
2024–2031 (USD MILLION) 167
TABLE 184 EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR OTHER AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 185 ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR OTHER AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY,
2024–2031 (USD MILLION) 168
TABLE 186 LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET FOR OTHER AESTHETIC THERAPEUTIC APPLICATIONS, BY COUNTRY,
2024–2031 (USD MILLION) 168
TABLE 187 DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 170
TABLE 188 DERMATOLOGY DEVICES MARKET FOR LASER-BASED, BY REGION,
2024–2031 (USD MILLION) 171
TABLE 189 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR LASER-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 190 EUROPE: DERMATOLOGY DEVICES MARKET FOR LASER-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 191 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR LASER-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 192 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR LASER-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 193 DERMATOLOGY DEVICES MARKET FOR ULTRASOUND-BASED, BY REGION,
2024–2031 (USD MILLION) 173
TABLE 194 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR ULTRASOUND-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 195 EUROPE: DERMATOLOGY DEVICES MARKET FOR ULTRASOUND-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 196 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR ULTRASOUND-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 197 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR ULTRASOUND-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 198 DERMATOLOGY DEVICES MARKET FOR LIGHT-BASED, BY REGION,
2024–2031 (USD MILLION) 175
TABLE 199 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR LIGHT-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 200 EUROPE: DERMATOLOGY DEVICES MARKET FOR LIGHT-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 201 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR LIGHT-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 202 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR LIGHT-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 203 DERMATOLOGY DEVICES MARKET FOR CRYOTHERAPY-BASED, BY REGION,
2024–2031 (USD MILLION) 177
TABLE 204 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR CRYOTHERAPY-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 205 EUROPE: DERMATOLOGY DEVICES MARKET FOR CRYOTHERAPY-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 177
TABLE 206 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR CRYOTHERAPY-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 207 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR CRYOTHERAPY-BASED,
BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 208 DERMATOLOGY DEVICES MARKET FOR RF-BASED, BY REGION,
2024–2031 (USD MILLION) 179
TABLE 209 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR RF-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 210 EUROPE: DERMATOLOGY DEVICES MARKET FOR RF-BASED, BY COUNTRY,
2024–2031 (USD MILLION) 179
TABLE 211 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR RF-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 212 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR RF-BASED, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 213 DERMATOLOGY DEVICES MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 181
TABLE 214 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 215 EUROPE: DERMATOLOGY DEVICES MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 216 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 217 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 218 DERMATOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 184
TABLE 219 DERMATOLOGY DEVICES MARKET FOR HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES, BY REGION, 2024–2031 (USD MILLION) 185
TABLE 220 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES, BY COUNTRY,
2024–2031 (USD MILLION) 185
TABLE 221 EUROPE: DERMATOLOGY DEVICES MARKET FOR HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 222 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES, BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 223 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES, BY COUNTRY,
2024–2031 (USD MILLION) 186
TABLE 224 DERMATOLOGY DEVICES MARKET FOR BEAUTY CENTERS, BY REGION,
2024–2031 (USD MILLION) 187
TABLE 225 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR BEAUTY CENTERS,
BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 226 EUROPE: DERMATOLOGY DEVICES MARKET FOR BEAUTY CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 227 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR BEAUTY CENTERS,
BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 228 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR BEAUTY CENTERS,
BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 229 DERMATOLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION,
2024–2031 (USD MILLION) 189
TABLE 230 NORTH AMERICA: DERMATOLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 231 EUROPE: DERMATOLOGY DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 232 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 233 LATIN AMERICA: DERMATOLOGY DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 234 DERMATOLOGY DEVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 192
TABLE 235 NON-SURGICAL SKIN TIGHTENING, 2024–2031 (IN MN) 192
TABLE 236 NORTH AMERICA: MACROECONOMIC INDICATORS 193
TABLE 237 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 194
TABLE 238 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 239 NORTH AMERICA: DIAGNOSTIC DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 240 NORTH AMERICA: TREATMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 195
TABLE 241 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 195
TABLE 242 NORTH AMERICA: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 243 NORTH AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 244 NORTH AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 245 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 197
TABLE 246 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 198
TABLE 247 US: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 199
TABLE 248 US: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199
TABLE 249 US: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199
TABLE 250 US: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 251 US: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 200
TABLE 252 US: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 253 US: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 254 US: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 202
TABLE 255 US: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 202
TABLE 256 US: DERMATOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 203
TABLE 257 CANADA: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 258 CANADA: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 259 CANADA: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 260 CANADA: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 205
TABLE 261 CANADA: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 262 CANADA: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 263 CANADA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 264 CANADA: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 207
TABLE 265 CANADA: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 207
TABLE 266 MACROECONOMIC INDICATORS FOR EUROPE 208
TABLE 267 EUROPE: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 208
TABLE 268 EUROPE: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 269 EUROPE: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 270 EUROPE: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 271 EUROPE: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 210
TABLE 272 EUROPE: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 273 EUROPE: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 274 EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE
, 2024–2031 (USD MILLION) 211
TABLE 275 EUROPE: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 212
TABLE 276 EUROPE: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 212
TABLE 277 GERMANY: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 213
TABLE 278 GERMANY: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 279 GERMANY: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 280 GERMANY: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 281 GERMANY: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 214
TABLE 282 GERMANY: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 283 GERMANY: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 284 GERMANY: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 216
TABLE 285 GERMANY: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 216
TABLE 286 GERMANY: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 217
TABLE 287 UK: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 217
TABLE 288 UK: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 289 UK: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 290 UK: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 291 UK: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 219
TABLE 292 UK: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 293 UK: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 294 UK: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 295 UK: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 221
TABLE 296 UK: DERMATOLOGY DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 221
TABLE 297 FRANCE: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 222
TABLE 298 FRANCE: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 299 FRANCE: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 300 FRANCE: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 301 FRANCE: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 223
TABLE 302 FRANCE: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 303 FRANCE: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 304 FRANCE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 305 FRANCE: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 225
TABLE 306 FRANCE: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 226
TABLE 307 ITALY: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 226
TABLE 308 ITALY: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 309 ITALY: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 310 ITALY: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 311 ITALY: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 228
TABLE 312 ITALY: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 313 ITALY: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 314 ITALY: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 315 ITALY: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 230
TABLE 316 ITALY: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 230
TABLE 317 SPAIN: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 231
TABLE 318 SPAIN: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 319 SPAIN: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 320 SPAIN: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 321 SPAIN: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 232
TABLE 322 SPAIN: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 323 SPAIN: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 324 SPAIN: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 234
TABLE 325 SPAIN: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 234
TABLE 326 SPAIN: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 235
TABLE 327 REST OF EUROPE: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 328 REST OF EUROPE: DIAGNOSTIC DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 329 REST OF EUROPE: TREATMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 330 REST OF EUROPE: DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 237
TABLE 331 REST OF EUROPE: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 332 REST OF EUROPE: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 333 REST OF EUROPE: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 334 REST OF EUROPE: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 239
TABLE 335 REST OF EUROPE: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 239
TABLE 336 MACROECONOMIC INDICATORS FOR ASIA PACIFIC 240
TABLE 337 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 241
TABLE 338 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 339 ASIA PACIFIC: DIAGNOSTIC DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 340 ASIA PACIFIC: TREATMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 341 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 242
TABLE 342 ASIA PACIFIC: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 243
TABLE 343 ASIA PACIFIC: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 243
TABLE 344 ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 244
TABLE 345 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 244
TABLE 346 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 245
TABLE 347 CHINA: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 348 CHINA: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 349 CHINA: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 350 CHINA: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 247
TABLE 351 CHINA: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 352 CHINA: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 247
TABLE 353 CHINA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 248
TABLE 354 CHINA: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 248
TABLE 355 CHINA: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 249
TABLE 356 JAPAN: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 249
TABLE 357 JAPAN: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 358 JAPAN: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 359 JAPAN: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 360 JAPAN: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 251
TABLE 361 JAPAN: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 362 JAPAN: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 363 JAPAN: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 364 JAPAN: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 253
TABLE 365 JAPAN: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 253
TABLE 366 INDIA: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 254
TABLE 367 INDIA: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 368 INDIA: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 369 INDIA: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 370 INDIA: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 255
TABLE 371 INDIA: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 372 INDIA: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE
, 2024–2031 (USD MILLION) 256
TABLE 373 INDIA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 374 INDIA: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 257
TABLE 375 INDIA: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 258
TABLE 376 REST OF ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 258
TABLE 377 REST OF ASIA PACIFIC: DIAGNOSTIC DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 378 REST OF ASIA PACIFIC: TREATMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 259
TABLE 379 REST OF ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 260
TABLE 380 REST OF ASIA PACIFIC: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 260
TABLE 381 REST OF ASIA PACIFIC: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 382 REST OF ASIA PACIFIC: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 383 REST OF ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 262
TABLE 384 REST OF ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 262
TABLE 385 MACROECONOMIC INDICATORS FOR LATIN AMERICA 263
TABLE 386 LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 263
TABLE 387 LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 263
TABLE 388 LATIN AMERICA: DIAGNOSTIC DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 389 LATIN AMERICA: TREATMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 390 LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 265
TABLE 391 LATIN AMERICA: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 265
TABLE 392 LATIN AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 393 LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 394 LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 267
TABLE 395 LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 267
TABLE 396 BRAZIL: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 268
TABLE 397 BRAZIL: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 398 BRAZIL: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 399 BRAZIL: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 400 BRAZIL: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 269
TABLE 401 BRAZIL: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 402 BRAZIL: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 403 BRAZIL: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 404 BRAZIL: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 271
TABLE 405 BRAZIL: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 272
TABLE 406 MEXICO: MOST COMMON MEDICAL AESTHETIC PROCEDURES, 2024 272
TABLE 407 MEXICO: DERMATOLOGY DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 408 MEXICO: DIAGNOSTIC DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 409 MEXICO: TREATMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 410 MEXICO: DERMATOLOGY DEVICES MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 274
TABLE 411 MEXICO: DIAGNOSTIC APPLICATION MARKET, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 412 MEXICO: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 413 MEXICO: AESTHETIC THERAPEUTIC APPLICATIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 414 MEXICO: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 276
TABLE 415 MEXICO: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 276
TABLE 416 REST OF LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 277
TABLE 417 REST OF LATIN AMERICA: DIAGNOSTIC DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 277
TABLE 418 REST OF LATIN AMERICA: TREATMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 278
TABLE 419 REST OF LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 278
TABLE 420 REST OF LATIN AMERICA: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 279
TABLE 421 REST OF LATIN AMERICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 422 REST OF LATIN AMERICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 423 REST OF LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 280
TABLE 424 REST OF LATIN AMERICA: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 281
TABLE 425 MIDDLE EAST & AFRICA: DERMATOLOGY DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 426 MIDDLE EAST & AFRICA: DIAGNOSTIC DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 427 MIDDLE EAST & AFRICA: TREATMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 282
TABLE 428 MIDDLE EAST & AFRICA: DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 283
TABLE 429 MIDDLE EAST & AFRICA: DIAGNOSTIC APPLICATION MARKET, BY TYPE,
2024–2031 (USD MILLION) 283
TABLE 430 MIDDLE EAST & AFRICA: MEDICAL THERAPEUTIC APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 431 MIDDLE EAST & AFRICA: AESTHETIC THERAPEUTIC APPLICATIONS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 432 MIDDLE EAST & AFRICA: DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 285
TABLE 433 MIDDLE EAST & AFRICA: DERMATOLOGY DEVICES MARKET, BY END USER,
2024–2031 (USD MILLION) 285
TABLE 434 OVERVIEW OF STRATEGIES ADOPTED BY KEY COMPANIES IN DERMATOLOGY DEVICES MARKET, JANUARY 2023−JUNE 2026 286
TABLE 435 DERMATOLOGY DEVICES MARKET: DEGREE OF COMPETITION 289
TABLE 436 DERMATOLOGY DEVICES MARKET: REGION FOOTPRINT 293
TABLE 437 DERMATOLOGY DEVICES MARKET: TYPE FOOTPRINT 294
TABLE 438 DERMATOLOGY DEVICES MARKET: APPLICATION FOOTPRINT 294
TABLE 439 DERMATOLOGY DEVICES MARKET: END USER FOOTPRINT 295
TABLE 440 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 297
TABLE 441 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2) 298
TABLE 442 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2) 298
TABLE 443 DERMATOLOGY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 301
TABLE 444 DERMATOLOGY DEVICES MARKET: DEALS, JANUARY 2023–JUNE 2026 303
TABLE 445 DERMATOLOGY DEVICES MARKET: EXPANSIONS, JANUARY 2023–JUNE 2026 304
TABLE 446 BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW 305
TABLE 447 BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED 306
TABLE 448 BAUSCH HEALTH COMPANIES INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 307
TABLE 449 BAUSCH HEALTH COMPANIES INC.: DEALS, JANUARY 2023–JUNE 2026 307
TABLE 450 SISRAM MEDICAL LTD: COMPANY OVERVIEW 309
TABLE 451 SISRAM MEDICAL LTD: PRODUCTS OFFERED 311
TABLE 452 SISRAM MEDICAL LTD: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 311
TABLE 453 LUMENIS BE LTD.: COMPANY OVERVIEW 313
TABLE 454 LUMENIS BE LTD.: PRODUCTS OFFERED 313
TABLE 455 LUMENIS BE LTD.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 314
TABLE 456 LUMENIS BE LTD.: DEALS, JANUARY 2023–JUNE 2026 314
TABLE 457 INMODE LTD.: COMPANY OVERVIEW 316
TABLE 458 INMODE LTD.: PRODUCTS OFFERED 317
TABLE 459 INMODE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 318
TABLE 460 BTL GROUP OF COMPANIES: COMPANY OVERVIEW 320
TABLE 461 BTL GROUP OF COMPANIES: PRODUCTS OFFERED 320
TABLE 462 EL.EN. S.P.A.: COMPANY OVERVIEW 322
TABLE 463 EL.EN. S.P.A.: PRODUCTS OFFERED 324
TABLE 464 EL.EN. S.P.A.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 324
TABLE 465 ABBVIE INC.: COMPANY OVERVIEW 325
TABLE 466 ABBVIE INC.: PRODUCTS OFFERED 326
TABLE 467 ABBVIE INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 327
TABLE 468 CYNOSURE LUTRONIC: COMPANY OVERVIEW 328
TABLE 469 CYNOSURE LUTRONIC: PRODUCTS OFFERED 329
TABLE 470 CYNOSURE LUTRONIC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 329
TABLE 471 CYNOSURE LUTRONIC: DEALS, JANUARY 2023–JUNE 2026 330
TABLE 472 CUTERA, INC.: COMPANY OVERVIEW 331
TABLE 473 CUTERA, INC.: PRODUCTS OFFERED 332
TABLE 474 CUTERA, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 332
TABLE 475 FOTONA: COMPANY OVERVIEW 333
TABLE 476 FOTONA: PRODUCTS OFFERED 333
TABLE 477 FOTONA: EXPANSIONS, JANUARY 2022–JUNE 2025 334
TABLE 478 CANDELA CORPORATION: COMPANY OVERVIEW 335
TABLE 479 JEISYS MEDICAL INC: COMPANY OVERVIEW 336
TABLE 480 AEROLASE: COMPANY OVERVIEW 337
TABLE 481 SCITON: COMPANY OVERVIEW 338
TABLE 482 ASTANZA LASER: COMPANY OVERVIEW 339
TABLE 483 HEINE OPTOTECHNIK GMBH & CO. KG: COMPANY OVERVIEW 340
TABLE 484 CANFIELD SCIENTIFIC, INC.: COMPANY OVERVIEW 341
TABLE 485 MICHELSON DIAGNOSTICS: COMPANY OVERVIEW 342
TABLE 486 GENESIS BIOSYSTEMS, INC: COMPANY OVERVIEW 343
TABLE 487 FOTOFINDER SYSTEMS GMBH: COMPANY OVERVIEW 344
TABLE 488 BEIJING TOPLASER TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 345
TABLE 489 GIGAAMEDICAL: COMPANY OVERVIEW 346
TABLE 490 DIMED LASER: COMPANY OVERVIEW 347
TABLE 491 LYNTON LASERS LTD: COMPANY OVERVIEW 348
TABLE 492 COURAGE+KHAZAKA ELECTRONIC GMBH: COMPANY OVERVIEW 349
TABLE 493 DERMATOLOGY DEVICE MARKET: RISK ASSESSMENT 362

LIST OF FIGURES

FIGURE 1 DERMATOLOGY DEVICES MARKET SEGMENTATION 37
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 41
FIGURE 3 GLOBAL DERMATOLOGY DEVICES MARKET, 2024–2031 42
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DERMATOLOGY DEVICES MARKET, 2023–2025 42
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF DERMATOLOGY DEVICES MARKET 43
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN DERMATOLOGY DEVICES MARKET, 2025 44
FIGURE 7 ASIA PACIFIC TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 45
FIGURE 8 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO DRIVE MARKET 46
FIGURE 9 TREATMENT DEVICES SEGMENT TO DOMINATE MARKET
DURING FORECAST PERIOD 47
FIGURE 10 AESTHETIC THERAPEUTIC APPLICATIONS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 47
FIGURE 11 LASER-BASED TECHNOLOGIES SEGMENT TO LEAD MARKET DURING
FORECAST PERIOD 48
FIGURE 12 HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 48
FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 49
FIGURE 14 DERMATOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 50
FIGURE 15 DERMATOLOGY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 61
FIGURE 16 DERMATOLOGY DEVICES MARKET: SUPPLY CHAIN ANALYSIS 67
FIGURE 17 DERMATOLOGY DEVICES MARKET: VALUE CHAIN ANALYSIS 68
FIGURE 18 DERMATOLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS 69
FIGURE 19 DERMATOLOGY DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74
FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN DERMATOLOGY DEVICES MARKET 75
FIGURE 21 PATENT ANALYSIS FOR DERMATOLOGY DEVICES,
JANUARY 2016–DECEMBER 2025 83
FIGURE 22 MARKET POTENTIAL OF AI IN DERMATOLOGY DEVICES MARKET 87
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE 94
FIGURE 24 KEY BUYING CRITERIA, BY TYPE 95
FIGURE 25 NORTH AMERICA: DERMATOLOGY DEVICES MARKET SNAPSHOT 193
FIGURE 26 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET SNAPSHOT 240
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN DERMATOLOGY DEVICES MARKET,
2023–2025 (USD MILLION) 288
FIGURE 28 DERMATOLOGY DEVICES MARKET SHARE ANALYSIS, 2025 (GLOBAL) 289
FIGURE 29 DERMATOLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 292
FIGURE 30 DERMATOLOGY DEVICES MARKET: COMPANY FOOTPRINT 293
FIGURE 31 DERMATOLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 296
FIGURE 32 EV/EBITDA OF KEY VENDORS 299
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 299
FIGURE 34 DERMATOLOGY DEVICES MARKET: BRAND/PRODUCT COMPARISON FOR DERMATOLOGY DEVICES 300
FIGURE 35 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2025) 306
FIGURE 36 SISRAM MEDICAL LTD: COMPANY SNAPSHOT (2025) 310
FIGURE 37 INMODE LTD.: COMPANY SNAPSHOT (2025) 317
FIGURE 38 EL.EN. S.P.A.: COMPANY SNAPSHOT (2025) 323
FIGURE 39 ABBVIE INC.: COMPANY SNAPSHOT (2025) 326
FIGURE 40 RESEARCH DESIGN 350
FIGURE 41 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION,
AND REGION 355
FIGURE 42 TOP-DOWN APPROACH 358
FIGURE 43 DATA TRIANGULATION 359

---

---